CIPO Patents = 3

EPO Patents = 4

Forward Citations = 93

Loading Chart...

2 inventors (with patents filed for the assignee):

Robert A Preti (8 out of 9 patents)

Andrew L Pecora (8 out of 17 patents)

8 patents: Sort by Forward Citations

1. 9534202 - Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency (2017-01-03),

2. 9533010 - Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency (2017-01-03),

3. 9034316 - Infarct area perfusion-improving compositions and methods of vascular injury repair (2015-05-19),

4. 8709403 - Compositions and methods of vascular injury repair (2014-04-29),

5. 8637005 - Compositions and methods of vascular injury repair (2014-01-28),

6. 8343485 - Compositions and methods of vascular injury repair (2013-01-01),

7. 8088370 - Compositions and methods of vascular injury repair (2012-01-03),

8. 7794705 - Compositions and methods of vascular injury repair (2010-09-14),

Amorcyte, Inc. is a biotechnology company focused on developing cell-based therapies for cardiovascular diseases. Their innovative approach aims to improve patient outcomes and quality of life through regenerative medicine. With a strong team of researchers and industry experts, Amorcyte is dedicated to advancing the field of cardiovascular medicine and bringing new treatment options to patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

8 Patents

#8 in Hackensack, NJ

#1,339 in New Jersey

#35,004 in US

Hackensack, NJ, United States of America

Amorcyte, Inc.

Forward Citations = 93

2 inventors:

Robert A Preti (8 out of 9 patents)

Andrew L Pecora (8 out of 17 patents)

Please report any incorrect information to support@idiyas.com

3 patents (CIPO):

Please report any incorrect information to support@idiyas.com

4 patents (EPO):

Please report any incorrect information to support@idiyas.com